Skip to main content
. 2015 Jul 30;6(30):28938–28948. doi: 10.18632/oncotarget.4727

Table 1. log2(fold change) and rank of snoRNA genes among the top-10 upregulated SNORs in tumours after at least one of the treatments, RA and THAL as sole agents, or in the combination RA + THAL.

log2(fold change) Rank
Gene RA-Ctrl (RA + THAL)-Ctrl THAL-Ctrl RA RA + THAL THAL
SNORA23 1.45 1.04 0.61 3 1 4
SNORA68 1.43 0.94 0.95 4 2 1
SNORA60 0.94 0.84 0.12 16 3 41
SNORD74 1.01 0.83 0.22 10 4 19
SNORD116–24 1.38 0.81 0.49 5 5 7
SNORA42 1.48 0.74 0.44 2 6 8
SNORA71A 1.24 0.69 0.62 6 7 3
SNORA3 1.13 0.67 0.10 8 8 43
SNORA73A 0.90 0.67 0.60 18 9 5
SNORA20 1.49 0.67 0.40 1 10 9
SNORA7B 1.08 0.59 0.23 9 11 18
SNORA24 0.74 0.49 0.40 26 15 10
SNORA71C 0.98 0.31 0.68 15 32 2
SNORD114–3 1.14 -0.01 0.51 7 206 6

A considerable degree of overlap was observed: 6 of 14 genes were in the top-10 after all three treatments.